Clinical Practice

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

Eli Lilly launches Zepbound KwikPen, a multi-dose device delivering a full month of tirzepatide. Here's what pharmacists need to know about access and pricing.

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

FDA approves YUVEZZI, the first combination eye drop for presbyopia. Learn how this dual-agent treatment works and what it means for pharmacy practice.

FDA Approves Oral Wegovy: First GLP-1 Pill for Weight Management

Explore the clinical implications of oral Wegovy (semaglutide) for chronic weight management, focusing on its pharmacology, efficacy, safety, and the pharmacist's role.

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

New research reveals concerning links between gabapentin use in chronic pain patients and increased dementia risk. Essential reading for pharmacists and healthcare providers.

Bridging the Diabetic Neuropathy Care Gap with the Help of a Pharmacist

Discover how pharmacists can close critical care gaps in diabetic neuropathy affecting 50% of diabetes patients through proactive screening, medication management, and patient education.

Expanding Pharmacists’ Role Through Test-and-Treat Services

Pharmacists are increasingly positioned to enhance community health by offering point-of-care test-and-treat (POCT-and-treat) services for common infectious conditions.

Veozah (fezolinetant) Updated with Warning on Rare Serious Liver Injury

FDA issues new liver injury warning for Veozah (fezolinetant), a menopause hot flash treatment. Learn about required monitoring, symptoms to watch, and safety updates.

FDA Approves Self-Administered Nasal Flu Vaccine, Expanding Access and Convenience

FDA Approves First Nasal Spray for Anaphylaxis Treatment

FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.